ATE183739T1 - N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie - Google Patents

N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie

Info

Publication number
ATE183739T1
ATE183739T1 AT92121896T AT92121896T ATE183739T1 AT E183739 T1 ATE183739 T1 AT E183739T1 AT 92121896 T AT92121896 T AT 92121896T AT 92121896 T AT92121896 T AT 92121896T AT E183739 T1 ATE183739 T1 AT E183739T1
Authority
AT
Austria
Prior art keywords
amnesia
prevention
treatment
acylpyrrolidine
preparation
Prior art date
Application number
AT92121896T
Other languages
English (en)
Inventor
Masaaki Toda
Shuichi Shinbayashida Ohuchida
Nishigyo-Ku Cho
Hiroyuki Ohno
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE183739T1 publication Critical patent/ATE183739T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
AT92121896T 1988-04-08 1989-04-06 N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie ATE183739T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8528888 1988-04-08

Publications (1)

Publication Number Publication Date
ATE183739T1 true ATE183739T1 (de) 1999-09-15

Family

ID=13854381

Family Applications (2)

Application Number Title Priority Date Filing Date
AT89106061T ATE117292T1 (de) 1988-04-08 1989-04-06 Antiamnesische pyrrolidin-derivate.
AT92121896T ATE183739T1 (de) 1988-04-08 1989-04-06 N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT89106061T ATE117292T1 (de) 1988-04-08 1989-04-06 Antiamnesische pyrrolidin-derivate.

Country Status (7)

Country Link
US (1) US5053414A (de)
EP (3) EP0965585A1 (de)
KR (1) KR0128160B1 (de)
AT (2) ATE117292T1 (de)
DE (2) DE68920632T2 (de)
ES (1) ES2070135T3 (de)
GR (1) GR3015831T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340284C (en) * 1987-03-19 1998-12-22 Zeneca Inc. Herbicidal substituted cyclic diones
JP2691442B2 (ja) * 1989-02-20 1997-12-17 株式会社ヤクルト本社 新規なプロリン誘導体
IT1241415B (it) * 1990-03-05 1994-01-14 Yason Srl Derivato dell'acido s-(2-tenoil)-tiolattico ad attivita' farmacologica
WO1991018891A1 (en) * 1990-06-04 1991-12-12 Pfizer Inc. Aromatic pyrrolidine and thiazolidine amides
CA2084204A1 (en) * 1990-06-07 1991-12-08 Akihiro Okubo Arylalkanoylamine derivative and drug containing the same
EP0468469A2 (de) * 1990-07-27 1992-01-29 Japan Tobacco Inc. Prolinderivate
US5506256A (en) * 1990-07-27 1996-04-09 Yoshitomi Pharmaceutical Industries, Ltd. Proline derivatives possessing prolyl endopeptidase-inhibitory activity
FR2669029B1 (fr) * 1990-11-14 1994-09-02 Adir Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2681864B1 (fr) * 1991-09-27 1995-03-31 Adir Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JP4806628B2 (ja) 2003-05-05 2011-11-02 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤
WO2005049027A2 (en) 2003-11-03 2005-06-02 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
US8034940B2 (en) 2006-08-09 2011-10-11 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5523107B2 (ja) 2006-11-30 2014-06-18 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
EP2481408A3 (de) 2007-03-01 2013-01-09 Probiodrug AG Neue Verwendung von Inhibitoren der Glutaminyl Cyclase
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE5255T1 (de) * 1978-09-05 1983-11-15 American Cyanamid Company Substituierte omega-aroyl(propionyl oder butyryl)-l-proline, diese enthaltende pharmazeutische verbindungen und verfahren zu ihrer herstellung.
US4880827A (en) * 1986-03-18 1989-11-14 Sumitomo Pharmaceuticals Company, Ltd. Pyrrolidine derivatives having inhibitory action for proline specific endopepidase
EP0268190B1 (de) * 1986-11-20 1993-06-16 Ono Pharmaceutical Co., Ltd. Prolinalderivate
EP0461677B1 (de) * 1987-02-23 1997-04-16 Ono Pharmaceutical Co., Ltd. Thiazolidin-Derivate
US4851428A (en) * 1987-03-06 1989-07-25 American Cyanamid Company Mono- and diepoxide derivatives of Δ22-LL-F28249 compounds
DE3712364A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue pyrrolidin-2-(1,3-dicarbonyl)-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
DE3712365A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
DE3742431A1 (de) * 1987-12-15 1989-07-13 Hoechst Ag Neue derivate cyclischer aminosaeuren, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
JPH0662591B2 (ja) * 1988-12-14 1994-08-17 株式会社ヤクルト本社 新規なチオプロリン誘導体
JP2691442B2 (ja) * 1989-02-20 1997-12-17 株式会社ヤクルト本社 新規なプロリン誘導体

Also Published As

Publication number Publication date
DE68929059D1 (de) 1999-09-30
EP0965585A1 (de) 1999-12-22
KR0128160B1 (ko) 1998-04-04
ES2070135T3 (es) 1995-06-01
DE68929059T2 (de) 2000-01-27
ATE117292T1 (de) 1995-02-15
KR900016122A (ko) 1990-11-12
GR3015831T3 (en) 1995-07-31
EP0345428B1 (de) 1995-01-18
EP0537802A2 (de) 1993-04-21
DE68920632D1 (de) 1995-03-02
DE68920632T2 (de) 1995-06-14
US5053414A (en) 1991-10-01
EP0537802A3 (en) 1993-06-02
EP0537802B1 (de) 1999-08-25
EP0345428A1 (de) 1989-12-13

Similar Documents

Publication Publication Date Title
DE68929059D1 (de) N-Acylpyrrolidine, Verfahren zur Herstellung und ihre Verwendung zur Prevention und/oder Behandlung von Amnesie
ATE169914T1 (de) Piperazin-derivate und ihre verwendung als calmodulin-inhibitoren
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
DK1105393T3 (da) Bicykliske piperidin- og piperazinforbindelser med 5-HT6-receptoraffinitet
ATE87306T1 (de) Prolinalderivate.
FI982436A0 (fi) Kondensoituneet heterosykliset yhdisteet
ES2103287T3 (es) Nuevos derivados de tiazolidina.
DE69430816D1 (de) Verwendung von Piperidin-Derivaten in der Behandlung von Schizophrenie
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
ATE137805T1 (de) Verfahren zur erhöhung von chemilumineszenz
DE3783754D1 (de) Prolin-derivate.
AT380471B (de) Verfahren zur herstellung von neuen 2-oxoazetidin-derivate
DE3675778D1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
ES2158290T3 (es) Derivados de tiazolidinona opticamente activos.
ATE226192T1 (de) Penizillaminamid-derivate
ATE47592T1 (de) Piperidinderivate und diese enthaltende fungizide sowie verfahren zur bekaempfung von pilzen.
DE69808607D1 (de) Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz
BR8903043A (pt) Processo para preparacao de compostos
IL59946A0 (en) Furgicidal compositions containing certain 3-cyclohexane-1-aminopropane derivatives and their production
DE3864463D1 (de) Gamma-l-glutanyl-4-nitoanilid-derivate und verfahren zur bestimmung von gamma-gtp-aktivitaet unter verwendung dieser derivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee